Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Fluorouracil (DB00544)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01298570Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerTreatment
NCT03142516FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance StatusTreatment
NCT02497157Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerTreatment
NCT02624726Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentTreatment
NCT01516216Study of Vitamin D in Untreated Metastatic Colorectal CancerTreatment